Chinese Journal of Dermatology ›› 2018, Vol. 51 ›› Issue (9): 707-709.doi: 10.3760/cma.j.issn.0412-4030.2018.09.024
Previous Articles Next Articles
He WEN1,
Received:2017-08-10
Revised:2017-10-02
Online:2018-09-15
Published:2018-08-30
He WEN. Topical application of probiotics in the prevention and treatment of atopic dermatitis[J].Chinese Journal of Dermatology, 2018, 51(9): 707-709.
| ［1］ | Salinas T, Piquette⁃Miller M. Within our skin［J］. Clin Pharmacol Ther, 2017,102（1）:8⁃12. doi: 10.1002/cpt.708.<br /> |
| ［2］ | Scharschmidt TC, Fischbach MA. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome［J］. Drug Discov Today Dis Mech, 2013,10（3⁃4）: e83⁃e89. doi: 10.1016/j.ddmec.2012.12.003.<br /> |
| ［3］ | Grice EA, Segre JA. The skin microbiome［J］. Nat Rev Microbiol, 2011,9（4）:244⁃253. doi: 10.1038/nrmicro2537.<br /> |
| ［4］ | Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis［J］. Genome Res, 2012,22（5）:850⁃859. doi: 10.1101/gr.131029.111.<br /> |
| ［5］ | Shi B, Bangayan NJ, Curd E, et al. The skin microbiome is different in pediatric versus adult atopic dermatitis［J］. J Allergy Clin Immunol, 2016,138（4）:1233⁃1236. doi: 10.1016/j.jaci.2016. 04.053.<br /> |
| ［6］ | Oh J, Freeman AF; NISC Comparative Sequencing Program, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies［J］. Genome Res, 2013,23（12）:2103⁃2114. doi: 10.1101/gr.159467.113.<br /> |
| ［7］ | Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis［J］. J Am Acad Dermatol, 2016,75（3）:481⁃493. doi: 10.1016/j.jaad.2016.04.066.<br /> |
| ［8］ | Zhang E, Tanaka T, Tajima M, et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects［J］. Microbiol Immunol, 2011,55（9）:625⁃632. doi: 10.1111/ j.1348⁃0421.2011.00364.x.<br /> |
| ［9］ | Chng KR, Tay AS, Li C, et al. Whole metagenome profiling reveals skin microbiome⁃dependent susceptibility to atopic dermatitis flare［J］. Nat Microbiol, 2016,1（9）:16106. doi: 10.1038/nmicrobiol. 2016.106.<br /> |
| ［10］ | Amagai M, Matsuyoshi N, Wang ZH, et al. Toxin in bullous impetigo and staphylococcal scalded⁃skin syndrome targets desmoglein 1［J］. Nat Med, 2000,6（11）:1275⁃1277. doi: 10.1038/81385.<br /> |
| ［11］ | Williams MR, Nakatsuji T, Sanford JA, et al. Staphylococcus aureus induces increased serine protease activity in keratinocytes［J］. J Invest Dermatol, 2017,137（2）:377⁃384. doi: 10.1016/j.jid.2016.10.008.<br /> |
| ［12］ | Son ED, Kim HJ, Park T, et al. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin⁃6 secretion［J］. J Dermatol Sci, 2014,74（1）:64⁃71. doi: 10.1016/j.jdermsci.2013.12.004. <br /> |
| ［13］ | Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus δ⁃toxin induces allergic skin disease by activating mast cells［J］. Nature, 2013,503（7476）:397⁃401. doi: 10.1038/nature12655.<br /> |
| ［14］ | Eisenbeis J, Peisker H, Backes CS, et al. The extracellular adherence protein （Eap） of Staphylococcus aureus acts as a proliferation and migration repressing factor that alters the cell morphology of keratinocytes［J］. Int J Med Microbiol, 2017,307（2）:116⁃125. doi: 10.1016/j.ijmm.2017.01.002.<br /> |
| ［15］ | Spaulding AR, Salgado⁃Pabón W, Kohler PL, et al. Staphylococcal and streptococcal superantigen exotoxins［J］. Clin Microbiol Rev, 2013,26（3）:422⁃447. doi: 10.1128/CMR.00104⁃12.<br /> |
| ［16］ | Nowrouzian FL, Lina G, Hodille E, et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema［J］. Br J Dermatol, 2017,176（2）:439⁃445. doi: 10.1111/bjd.15138.<br /> |
| ［17］ | Niebuhr M, Scharonow H, Gathmann M, et al. Staphylococcal exotoxins are strong inducers of IL⁃22: a potential role in atopic dermatitis［J］. J Allergy Clin Immunol, 2010,126（6）:1176⁃1183. doi: 10.1016/j.jaci.2010.07.041.<br /> |
| ［18］ | Fujita H. The role of IL⁃22 and Th22 cells in human skin diseases［J］. J Dermatol Sci, 2013,72（1）:3⁃8. doi: 10.1016/j.jdermsci.2013. 04.028.<br /> |
| ［19］ | Hradetzky S, Werfel T, Rösner LM. Autoallergy in atopic dermatitis［J］. Allergo J Int, 2015,24（1）:16⁃22. doi: 10.1007/s40629⁃015⁃0037⁃5.<br /> |
| ［20］ | Biedermann T, Skabytska Y, Kaesler S, et al. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation［J］. Front Immunol, 2015,6:353. doi: 10.3389/fimmu.2015.00353.<br /> |
| ［21］ | Hanzelmann D, Joo HS, Franz⁃Wachtel M, et al. Toll⁃like receptor 2 activation depends on lipopeptide shedding by bacterial surfac⁃tants［J］. Nat Commun, 2016,7:12304. doi: 10.1038/ncomms12304.<br /> |
| ［22］ | Jun SH, Lee JH, Kim SI, et al. Staphylococcus aureus⁃derived membrane vesicles exacerbate skin inflammation in atopic dermatitis［J］. Clin Exp Allergy, 2017,47（1）:85⁃96. doi: 10.1111/cea.12851.<br /> |
| ［23］ | Nakatsuji T, Chen TH, Two AM, et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine ［J］. J Invest Dermatol, 2016,136（11）:2192⁃2200. doi: 10.1016/j.jid.2016.05.127.<br /> |
| ［24］ | Travers JB. Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis［J］. J Invest Dermatol, 2014,134（8）:2069⁃2071. doi: 10.1038/jid.2014.122.<br /> |
| ［25］ | Koymans KJ, Feitsma LJ, Brondijk TH, et al. Structural basis for inhibition of TLR2 by staphylococcal superantigen⁃like protein 3 （SSL3）［J］. Proc Natl Acad Sci U S A, 2015,112（35）:11018⁃11023. doi: 10.1073/pnas.1502026112. <br /> |
| ［26］ | Askarian F, van Sorge NM, Sangvik M, et al. A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2⁃mediated NF⁃κB signaling［J］. J Innate Immun, 2014,6（4）:485⁃498. doi: 10.1159/000357618.<br /> |
| ［27］ | Myles IA, Williams KW, Reckhow JD, et al. Transplantation of human skin microbiota in models of atopic dermatitis［J］. JCI Insight, 2016,1（10）: e86955. doi: 10.1172/jci.insight.86955.<br /> |
| ［28］ | Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals［J］. Science, 2012,337（6098）:1115⁃1119. doi: 10.1126/science.1225152.<br /> |
| ［29］ | Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll⁃like receptor 3⁃dependent inflammation after skin injury［J］. Nat Med, 2009,15（12）:1377⁃1382. doi: 10.1038/nm. 2062.<br /> |
| ［30］ | Volz T, Skabytska Y, Guenova E, et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL⁃10⁃producing dendritic cells and regulatory Tr1 cells［J］. J Invest Dermatol, 2014,134（1）:96⁃104. doi: 10.1038/jid.2013.291.<br /> |
| ［31］ | Guéniche A, Bastien P, Ovigne JM, et al. Bifidobacterium longum lysate, a new ingredient for reactive skin［J］. Exp Dermatol, 2010,19（8）:e1⁃8. doi: 10.1111/j.1600⁃0625.2009.00932.x.<br /> |
| ［32］ | Lopes EG, Moreira DA, Gullón P, et al. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays［J］. J Appl Microbiol, 2017,122（2）:450⁃461. doi: 10.1111/jam.13349.<br /> |
| ［33］ | Seité S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients ⁃ relationship with the skin microbiota modification［J］. Clin Cosmet Investig Dermatol, 2017,10（1）:25⁃33. doi: 10.2147/CCID.S121910.<br /> |
| ［34］ | Park SB, Im M, Lee Y, et al. Effect of emollients containing vegetable⁃derived lactobacillus in the treatment of atopic dermatitis symptoms: split⁃body clinical trial［J］. Ann Dermatol, 2014,26（2）:150⁃155. doi: 10.5021/ad.2014.26.2.150.<br /> |
| ［35］ | Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis［J］. Sci Transl Med, 2017,9（378）: eaah4680. doi: 10.1126/scitranslmed.aah4680.<br /> |
|
